Spatial Genomics
Private Company
Total funding raised: $15.5M
Overview
Spatial Genomics is a private, early-stage biotech company commercializing a proprietary spatial multi-omics platform called GenePS. Its core technology, seqFISH, combines high-resolution imaging with combinatorial molecular barcoding to map hundreds to tens of thousands of biomolecules within single cells in their native tissue context, offering superior multiplexing and single-molecule sensitivity. The company is positioned to serve the rapidly growing research tools market, targeting academic, biopharma, and diagnostic researchers seeking to understand complex biology in health and disease.
Technology Platform
Sequential Fluorescence In Situ Hybridization (seqFISH) combined with high-resolution confocal imaging and advanced fluidics for highly multiplexed, spatial multi-omic analysis of RNA, DNA, and protein within intact cells and tissues.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Spatial Genomics competes in the crowded spatial genomics market against companies like 10x Genomics (Visium), NanoString (GeoMx), Akoya Biosciences, and newer entrants like Vizgen and Resolve Biosciences. It differentiates primarily through its seqFISH technology, which offers potentially higher multiplexing and integrated DNA/protein detection from a single platform.